Salpingectomy at Cesarean Delivery for Ovarian Cancer Reduction (SCORE)
| Status: | Completed |
|---|---|
| Conditions: | Ovarian Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 25 - Any |
| Updated: | 10/7/2017 |
| Start Date: | April 2015 |
| End Date: | September 2017 |
Complete Salpingectomy Versus Standard Postpartum Tubal Ligation at the Time of Cesarean Delivery- a Randomized Controlled Study
To compare the feasibility and surgical outcomes between complete salpingectomy and standard
postpartum tubal ligation (partial salpingectomy) at the time of cesarean delivery in women
with undesired future fertility. as a possible ovarian cancer risk-reducing procedure.
postpartum tubal ligation (partial salpingectomy) at the time of cesarean delivery in women
with undesired future fertility. as a possible ovarian cancer risk-reducing procedure.
All pregnant women receiving prenatal care within the UAB Health System, and planning to
undergo tubal ligation at the time of their scheduled cesarean delivery (primary or repeat)
will be approached about the study. Patients will be randomized to receive either the
standard tubal ligation practice at our institution (modified Pomeroy procedure or Parkland)
or a complete salpingectomy. The objective of this trial is to evaluate if a complete
salpingectomy can be performed safely and comparable to a standard postpartum tubal ligation.
undergo tubal ligation at the time of their scheduled cesarean delivery (primary or repeat)
will be approached about the study. Patients will be randomized to receive either the
standard tubal ligation practice at our institution (modified Pomeroy procedure or Parkland)
or a complete salpingectomy. The objective of this trial is to evaluate if a complete
salpingectomy can be performed safely and comparable to a standard postpartum tubal ligation.
Inclusion Criteria:
- All pregnant women > 25 years receiving prenatal care within the UAB Health System,
and planning to undergo tubal ligation at the time of their scheduled cesarean
delivery (primary or repeat)
- Informed consent obtained
Exclusion Criteria:
- Inability to obtain informed consent
- Fetal death or anomalies
- Preterm delivery < 36 weeks gestation
- Immune-compromising disease
- Chronic steroid use
- Chronic prophylactic or therapeutic anti-coagulation
- Patients no followed in our regional health system
- Known BRCA mutation carrier status
- Age < 25 years
We found this trial at
1
site
1720 2nd Ave S
Birmingham, Alabama 35233
Birmingham, Alabama 35233
(205) 934-4011
Principal Investigator: Akila Subramaniam, MD
Phone: 205-934-7879
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
Click here to add this to my saved trials
